Hiscox (LON:HSX - Get Free Report) had its price objective raised by equities researchers at Royal Bank Of Canada from GBX 1,125 ($15.10) to GBX 1,300 ($17.45) in a research report issued to clients and investors on Friday, Marketbeat reports. The brokerage currently has a "sector perform" rating on the stock. Royal Bank Of Canada's price objective points to a potential upside of 1.09% from the stock's previous close.
A number of other research firms have also weighed in on HSX. Berenberg Bank began coverage on Hiscox in a report on Thursday, May 29th. They issued a "buy" rating and a GBX 1,450 ($19.46) target price on the stock. Peel Hunt restated a "buy" rating and issued a GBX 1,460 ($19.60) target price on shares of Hiscox in a report on Thursday, July 3rd.
Read Our Latest Analysis on Hiscox
Hiscox Price Performance
Shares of HSX stock traded up GBX 6 ($0.08) during trading hours on Friday, reaching GBX 1,286 ($17.26). The company had a trading volume of 831,212 shares, compared to its average volume of 2,072,726. Hiscox has a 12 month low of GBX 1,008 ($13.53) and a 12 month high of GBX 1,360 ($18.26). The business has a fifty day simple moving average of GBX 1,255.80 and a 200-day simple moving average of GBX 1,164.21. The company has a market cap of £5.54 billion, a price-to-earnings ratio of 7.89, a price-to-earnings-growth ratio of -2.30 and a beta of 0.65.
Hiscox Company Profile
(
Get Free Report)
Hiscox Ltd, through its subsidiaries, provides insurance and reinsurance services in the United Kingdom, Europe, the United States, and internationally. The company operates through four segments: Hiscox Retail, Hiscox London Market, Hiscox Re & ILS, and Corporate Centre. It offers commercial insurance for small-and medium-sized businesses; and personal lines cover, including high-value household, fine art, and luxury motor, as well as artwork, antiques, classic cars, jewelry, collectables, and other assets through brokers, partners, and direct-to-consumers.
Recommended Stories
Before you consider Hiscox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hiscox wasn't on the list.
While Hiscox currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.